Key Highlights

  • Lam Research (NASDAQ:LRCX) reported non-GAAP diluted earnings of USD 2.20 per share for its fiscal first quarter of 2027 on Wednesday, October 21, 2026, against the consensus estimate of USD 2.18.
  • Systems revenue, meaning sales of new etch and deposition tools, rose about 61% to USD 5.73 billion, while customer support-related revenue grew about 40% to USD 2.49 billion but was flat on the June quarter.
  • Operating cash flow reached USD 3.50 billion against USD 1.46 billion in the June quarter, funding about USD 1.02 billion of buybacks and USD 325.4 million of dividends.
  • China accounted for 35% of revenue, and guidance for the December quarter is USD 8.60 billion, plus or minus USD 400 million, with non-GAAP earnings of USD 2.33, plus or minus USD 0.15.

A Quarter Driven by New Tools

Lam Research (NASDAQ:LRCX), which supplies wafer fabrication equipment to chipmakers, reported results for its fiscal first quarter of 2027, ended Sunday, September 27, 2026, on Wednesday, October 21, 2026. Revenue was USD 8.22 billion, up 22% on the June quarter and 54% on the year-ago USD 5.32 billion. Non-GAAP diluted earnings were USD 2.20, against the consensus estimate of USD 2.18; GAAP earnings were USD 2.19, against USD 1.24 a year earlier. Systems revenue reached USD 5.73 billion, against USD 4.25 billion in June and USD 3.55 billion a year earlier. Customer support-related and other revenue was USD 2.49 billion, almost unchanged from USD 2.47 billion in June. GAAP gross margin rose to 52.3% from 50.4%, and GAAP operating margin reached 40.0%.

How the Mix Shift Shows Up in Cash

For Lam Research (NASDAQ:LRCX), the split between tools and service explains the quarter. Systems revenue rose to about 70% of sales from about 67% a year earlier, on simple arithmetic, so new fab capacity rather than the installed base drove growth. Even with the heavier tool mix, GAAP gross margin rose 1.9 points, which suggests volume absorbed fixed factory costs. Operating cash flow of USD 3.50 billion was about 2.4 times the June figure, and deferred revenue, which records amounts billed before revenue is recognised, rose to USD 2.66 billion from USD 2.43 billion. Buybacks and dividends together took about 38% of operating cash flow, while cash rose to USD 7.45 billion. Dividends declared per share rose to USD 0.33 from USD 0.26.

Risks and What to Watch

The first risk for Lam Research (NASDAQ:LRCX) is that systems demand proves lumpy, since tool orders follow customer fab schedules while flat support revenue gives less cushion than before. The second is geography, with China still 35% of revenue, Korea 20% and Taiwan 18%, which leaves sales exposed to export rules and to a few large customers. The third is the pace of growth: the December guide of USD 8.60 billion, plus or minus USD 400 million, implies sequential growth of about 5% at the midpoint after 22% in the September quarter. Investors should watch whether the December quarter delivers the guided 40.5% operating margin, plus or minus one point, and non-GAAP earnings of USD 2.33, plus or minus USD 0.15.

Where Things Stand

The answer is that Lam Research (NASDAQ:LRCX) grew systems revenue 61% because customers bought new tools faster than they added service spending. That mix lifted margins rather than diluting them and turned into USD 3.50 billion of operating cash flow. Earnings of USD 2.20 edged past the consensus estimate of USD 2.18. The next catalysts are the December-quarter report against guidance of USD 8.60 billion and any update on the China share. Guidance is a company forecast, not a guarantee, and this is not investment advice.